France Cardiovascular Ultrasound Market

Cardiovascular Ultrasound Market in France (Statistics & Outlook) 2030

The France cardiovascular ultrasound market was valued at $162.97 million in 2020, and is projected to reach $252.90 million by 2030, registering a CAGR of 4.7% from 2021 to 2030. The growth of the France cardiovascular ultrasound market is driven by increase in incidence of cardiovascular diseases, change in the lifestyle of the population, rise in the number of hospitals and clinics. Moreover, surge in the geriatric population and rise in number of product launches associated to the cardiovascular ultrasound also contributes to the growth of the market. 

In addition, rise in health awareness toward cardiovascular diseases among the adult population supplements the market growth. However, factors such as economic influence of approving new technologies and insufficient reimbursement scenario impede the growth of the France cardiovascular ultrasound market. Conversely, technological advancements leading in cardiac specific technologies such as tissue enhancements, lateral gain control, advanced dynamic flow, tissue Doppler, and stress echo provide lucrative opportunities for the growth of the market.

A cardiovascular ultrasound is an ultrasound that looks specifically at your heart and blood vessels. This type of imaging can be used to assess the function of different parts of your cardiovascular system. The cardiovascular ultrasound is a useful tool to evaluate the structure and function of the heart and associated vessels. It is a fast, easy, and painless evaluation that uses ultrasound waves to produce images of the heart. Cardiac ultrasound device is relatively inexpensive, lightweight, and portable device and offers the features that overcome the need of physical examination.

Impact of COVID-19 Pandemic on Cardiovascular Ultrasound Market in France (Pre & Post Analysis)

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. The ultrasound device manufacturing was disturbed in 2020 due to the slowdown of distribution chain of raw materials. Moreover, the manpower needed for the manufacturing plants could not come to work due to lockdown imposed, which shut down the manufacturing plants of the ultrasound devices. 

Overall impact of the COVID-19 pandemic on the France cardiovascular ultrasound market was recorded to be negative owing to the factors such as disturbance in the distribution chain, financial problems, scarcity of laborers at manufacturing plants, and decrease in the number of ultrasound diagnosis performed amid the pandemic. However, this situation is expected to change post COVID-19 pandemic in the coming years.

The France cardiovascular ultrasound market is segmented into clinical application, technology, device display, age group, and end user. On the basis of clinical application, the market is categorized into diagnostic cardiology, interventional cardiology, and vascular diagnostic. Diagnostic cardiology is further categorized as transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiogram. Interventional cardiology is further categorized as electrophysiology procedure, septal closure procedure, and others. 

Vascular diagnostic is further categorized as aortoiliac duplex, carotid duplex, lower extremity arterial duplex, iliocaval duplex, and mesenteric duplex. By technology, it is classified into 2D, 3D & 4D, and doppler imaging. By device display, it is classified into color display and black & white display. By age group, it is classified into adult and pediatric. By end user, it is classified into private clinics, public hospitals, cardiology centers, and ambulatory centers.

Clinical Application Segment Review

By clinical application, the diagnostic cardiology segment dominated the France cardiovascular ultrasound market in 2020, and is anticipated to continue this trend during the forecast period. Key factors such as increase in the prevalence of heart diseases, development of new & advanced cardiovascular ultrasound devices, and rise in focus toward diagnosis through ultrasound devices is expected to drive the growth of the segment. 

Technology Segment Review

By technology, it is classified into 2D, 3D & 4D, and doppler imaging. The 2D segment accounted for maximum France cardiovascular ultrasound market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to increase in the geriatric population and change in lifestyle of the people. However, the 3D & 4D segment exhibits fastest growth from 2021 to 2030 owing to increase in the number of heart patients and rise in the awareness of diagnosis via ultrasound devices. Moreover, availability of large number of advanced hospitals, presence of skilled medical professionals, large number of ambulatory centers, and wide usage of medical nonwoven products are anticipated to drive the growth of the segment.

Device Display Segment Review

By device display, it is classified into color display and black and white display. The color display segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased use of color display and rise in the benefits of color display which is expected to drive the France cardiovascular ultrasound market growth. 

Age Group Segment Review

By age group, it is classified into adult and pediatric. The adult segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased population of adult people and surge in incidence of cardiovascular diseases (CVDs) in that age group, which is expected to drive the market growth. 

End User Segment Review

By end user, it is classified into private clinics, public hospitals, cardiology centers, and ambulatory centers. The public hospitals segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increase in the number of hospitals and clinics and increase in number of government initiatives for the treatment. However, the cardiology centers segment exhibits fastest growth from 2021 to 2030 owing to increase in the number of healthcare centers and surge in incidences of heart diseases. Moreover, availability of number of advanced hospitals, presence of skilled professionals, and wide usage of ultrasound are anticipated to drive the growth of the France cardiovascular ultrasound market segment.

Key Benefits for Stakeholders

• This report provides a detailed quantitative analysis of the current France cardiovascular ultrasound market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing market opportunities. 
• An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of factors that drive and restrain the growth of the France cardiovascular ultrasound market is provided.
• The projections in this report are made by analyzing the current trends and future France cardiovascular ultrasound market potential from2020 to 2030, in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key players within the France cardiovascular ultrasound market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the market.

 France Cardiovascular Ultrasound Market Report Highlights